NO20040766L - Fremgangsmate for fremstilling av glykopeptidfosfonatderivater. - Google Patents

Fremgangsmate for fremstilling av glykopeptidfosfonatderivater.

Info

Publication number
NO20040766L
NO20040766L NO20040766A NO20040766A NO20040766L NO 20040766 L NO20040766 L NO 20040766L NO 20040766 A NO20040766 A NO 20040766A NO 20040766 A NO20040766 A NO 20040766A NO 20040766 L NO20040766 L NO 20040766L
Authority
NO
Norway
Prior art keywords
preparation
phosphonate derivatives
glycopeptide phosphonate
glycopeptide
derivatives
Prior art date
Application number
NO20040766A
Other languages
English (en)
Other versions
NO331661B1 (no
Inventor
Martin S Linsell
Michael R Leadbetter
Junning Lee
Jyanwei Liu
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of NO20040766L publication Critical patent/NO20040766L/no
Publication of NO331661B1 publication Critical patent/NO331661B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20040766A 2001-08-24 2004-02-20 Fremgangsmåte for fremstilling av glykopeptidfosfonatderivater. NO331661B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31483101P 2001-08-24 2001-08-24
PCT/US2002/026853 WO2003029270A2 (en) 2001-08-24 2002-08-23 Process for preparing glycopeptide phosphonate derivatives

Publications (2)

Publication Number Publication Date
NO20040766L true NO20040766L (no) 2004-04-29
NO331661B1 NO331661B1 (no) 2012-02-20

Family

ID=23221639

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040766A NO331661B1 (no) 2001-08-24 2004-02-20 Fremgangsmåte for fremstilling av glykopeptidfosfonatderivater.

Country Status (15)

Country Link
US (5) US6979723B2 (no)
EP (1) EP1418933B1 (no)
JP (2) JP4116555B2 (no)
KR (1) KR100909438B1 (no)
CN (1) CN1246036C (no)
AT (1) ATE361312T1 (no)
AU (1) AU2002326739B2 (no)
BR (1) BRPI0211997B8 (no)
CA (1) CA2457863C (no)
DE (1) DE60219927T2 (no)
DK (1) DK1418933T3 (no)
ES (1) ES2286274T3 (no)
NO (1) NO331661B1 (no)
TW (1) TWI275594B (no)
WO (1) WO2003029270A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA75083C2 (uk) * 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
TWI275594B (en) * 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
US6951963B2 (en) 2002-06-17 2005-10-04 Theravance, Inc. Process for preparing N-protected β-amino aldehyde compounds
TWI342312B (en) * 2003-10-22 2011-05-21 Theravance Inc Hydrochloride salts of a glycopeptide phosphonate derivative
EP2753637A1 (en) 2011-09-09 2014-07-16 Sandoz AG Process for the synthesis of telavancin, its pharmaceutically acceptable salts as well as an n-protected imine-derivative of telavancin
EP2753638A1 (en) 2011-09-09 2014-07-16 Sandoz AG Process for the synthesis of telavancin and its pharmaceutically acceptable salts as well as n-protected derivatives thereof
EP2969004A4 (en) 2013-03-15 2016-09-21 Melinta Therapeutics Inc METHOD FOR THE TREATMENT OF INFECTIONS IN OVERWEIGHT AND ADIPOSIVE PATIENTS USING ANTIBIOTICS
WO2016063246A1 (en) * 2014-10-22 2016-04-28 Sun Pharmaceutical Industries Limited Crystalline form r of tedizolid phosphate
CA2976384A1 (en) 2015-02-23 2016-09-01 Theravance Biopharma Antibiotics Ip, Llc Doses and methods of administering telavancin
CN106467570B (zh) * 2015-08-14 2020-04-07 正大天晴药业集团股份有限公司 糖肽类抗生素的还原烷基化方法
CN106631902A (zh) * 2016-09-23 2017-05-10 上海步越化工科技有限公司 一种特拉万星侧链癸基(2‑氧代乙基)氨基甲酸9h‑芴‑9‑甲基酯的制备方法
CN107629116B (zh) * 2017-09-08 2021-05-07 福建省微生物研究所 一种特拉万星的纯化方法
CN107629115B (zh) * 2017-09-08 2021-05-07 福建省微生物研究所 一种特拉万星的纯化方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3160632A (en) 1961-01-30 1964-12-08 Stauffer Chemical Co Aminomethylenephosphinic acids, salts thereof, and process for their production
US4643967A (en) * 1983-07-07 1987-02-17 Bryant Bernard J Antibody method for lowering risk of susceptibility to HLA-associated diseases in future human generations
IL78597A0 (en) 1985-04-25 1986-08-31 Lilly Co Eli Novel glycopeptide derivatives
US4698327A (en) 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4643987A (en) 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
DE68925806T2 (de) 1988-12-27 1996-09-26 Lepetit Spa C63-Amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplaninen
NZ236393A (en) 1989-12-13 1992-05-26 Lilly Co Eli N-alkylated glycopeptide derivatives prepared from antibiotics a82846 series and pa-42867-a; pharmaceutical compositions
DK0596929T3 (da) 1991-07-29 1995-09-11 Lepetit Spa Amidderivater af antibiotikum A 40926
US5750509A (en) 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
TW457248B (en) 1994-01-28 2001-10-01 Lilly Co Eli Glycopeptide antibiotic derivatives
US5840684A (en) 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5561714A (en) * 1994-12-12 1996-10-01 Tektronix, Inc. Scrambling system for serial digital video
US5919756A (en) 1996-06-28 1999-07-06 Eli Lilly And Company Amides
US5939382A (en) 1996-11-21 1999-08-17 Eli Lilly And Company Reducing agent for reductive alkylation of glycopeptide antibiotics
US5952466A (en) 1997-11-12 1999-09-14 Eli Lilly And Company Reductive alkylation of glycopeptide antibiotics
US5916873A (en) 1997-04-17 1999-06-29 Eli Lilly And Company Teicoplanin derivatives
EP1060189A1 (en) 1998-02-20 2000-12-20 Advanced Medicine, Inc. Derivatives of glycopeptide antibacterial agents
US6518242B1 (en) 1998-02-20 2003-02-11 Theravance, Inc. Derivatives of glycopeptide antibacterial agents
IL140093A0 (en) * 1998-12-23 2002-02-10 Advanced Medicine Inc Glycopeptide derivatives and pharmaceutical compositions containing the same
JP2000281694A (ja) * 1999-03-29 2000-10-10 Tanaka Kikinzoku Kogyo Kk 有機金属気相エピタキシー用の有機金属化合物
AU4054900A (en) 1999-04-02 2000-10-23 Advanced Medicine East, Inc. Desleucyl glycopeptide antibiotics and methods of making same
CA2726789A1 (en) * 2000-02-05 2001-11-08 Theravance, Inc. Cyclodextrin containing glycopeptide antibiotic compositions
US6831150B2 (en) * 2000-05-02 2004-12-14 Theravance, Inc. Reductive alkylation process
WO2001098329A1 (en) * 2000-06-22 2001-12-27 Theravance, Inc. Polyhydroxy glycopeptide derivatives
UA75083C2 (uk) * 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
KR20020013174A (ko) * 2000-08-11 2002-02-20 민경윤 경구 흡수율이 낮은 약물의 흡수율을 증가시키기 위한경구용 조성물
TWI275594B (en) * 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
US7726104B2 (en) * 2006-06-21 2010-06-01 Cp Packaging, Inc. Vacuum packaging system with end cutter

Also Published As

Publication number Publication date
US20110060122A1 (en) 2011-03-10
US7728104B2 (en) 2010-06-01
EP1418933A2 (en) 2004-05-19
EP1418933A4 (en) 2004-10-27
KR100909438B1 (ko) 2009-07-28
CA2457863A1 (en) 2003-04-10
US20080227963A1 (en) 2008-09-18
US20060264607A1 (en) 2006-11-23
US6979723B2 (en) 2005-12-27
US20050020488A1 (en) 2005-01-27
WO2003029270A2 (en) 2003-04-10
CN1246036C (zh) 2006-03-22
US7074890B2 (en) 2006-07-11
JP2005526000A (ja) 2005-09-02
EP1418933B1 (en) 2007-05-02
US20030069391A1 (en) 2003-04-10
NO331661B1 (no) 2012-02-20
CA2457863C (en) 2012-01-03
BRPI0211997B1 (pt) 2016-10-11
US8093354B2 (en) 2012-01-10
DE60219927T2 (de) 2008-01-17
JP2008208130A (ja) 2008-09-11
DE60219927D1 (de) 2007-06-14
KR20040028999A (ko) 2004-04-03
ATE361312T1 (de) 2007-05-15
JP4116555B2 (ja) 2008-07-09
BR0211997A (pt) 2006-04-04
TWI275594B (en) 2007-03-11
ES2286274T3 (es) 2007-12-01
DK1418933T3 (da) 2007-06-11
US7301004B2 (en) 2007-11-27
CN1547481A (zh) 2004-11-17
BRPI0211997B8 (pt) 2016-11-16
WO2003029270A3 (en) 2003-09-04
AU2002326739B2 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
NO20040766L (no) Fremgangsmate for fremstilling av glykopeptidfosfonatderivater.
AU1613601A (en) Cleaning process which uses ultrasonic waves
DK0828717T3 (da) Fremgangsmåde til fremstilling af 3-haloalkyl-1H-pyrazol
PL345215A1 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
NO20050090L (no) Fremgangsmate for fremstilling av et virus-inaktivert trombinpreparat
AU2002302642A1 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
CY1109343T1 (el) Παραγωγα αζετιδινης, η παρασκευη τους και οι φαρμακευτικες ενωσεις που τα περιεχουν
AU2003221270A8 (en) Nanocomposites: products, process for obtaining them and uses thereof
AU1613801A (en) Cleaning process which uses ultrasonic waves
WO2003093282A8 (en) Preparation of biphosphonic acids and salts thereof
NO20040779L (no) Fremgangsmate for fremstilling av glykopeptidderivater
AU1817902A (en) Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)
BR9808533A (pt) Método para estimular a produção de hemácias
TR200403039T1 (tr) Seramik parçalarının süslenmesi için yöntem ve donatım ile buradan elde edilen ürünler
PT1064265E (pt) Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona
AU6584601A (en) Method for producing indols
GB9805808D0 (en) Process for producing meat products
TW200407314A (en) Preparation of 4, 6-dichloro-5-fluoropyrimidine
IL161800A0 (en) Method for the production of desclarithromycin, and intermediateproducts
IL154764A0 (en) Process to produce halo-4-phenoxyquinolines
IL161079A0 (en) A strain of streptomyces flavidovirens and process for the manufacture of pravastatin utilizing the same
YU53302A (sh) Postupci za pripremanje polimorfa klaritromicina
ZA200307447B (en) Process for the preparation of synthesis gas.

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THERAVANCE BIOPHARMA R&D IP, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THERAVANCE BIOPHARMA ANTIBIOTICS IP, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: CUMBERLAND PHARMACEUTICALS INC., US

MM1K Lapsed by not paying the annual fees